A leading provider of
innovative DNA Screening solutions
IGH/CCND1 Translocation, Dual Fusion LPH021
Reciprocal translocations involving the IGH and CCND1 (BCL1) loci were frequently reported in B-CLL patients. The probe set for the t(11;14) translocation has been provided on the CLL panel to enable atypical B-CLL patients to be distinguished from possible MCL patients following the guidelines of the UK ACC Professional Standards Committee.
IGH/CCND1 Translocation, Dual Fusion
Cat. No. LPH 021-S (5 tests)
Cat. No. LPH 021 (10 tests)
This webpage could contain information on product details or information not valid in your country or region. Please be aware that we do not take any responsibility for accessing such information, which may not comply with any legal process, regulation, registration or usage in the country of your origin. If you are a resident of a country other than those to which this site is directed, contact your local Cytocell distributor to obtain the appropriate product information for your country of residence.
Developed &produced in the UK